Literature DB >> 32578960

"Individual Placement and Support" boosts employment for early psychosis clients, even when baseline rates are high.

David H Erickson1,2, Meighen M Roes1,3,4,5, Alessandra DiGiacomo1,4,5, Amy Burns1,4.   

Abstract

AIM: Individual Placement and Support is an effective vocational intervention for increasing competitive employment for people with severe mental illness. Little is known, however, about its effectiveness in the context of early psychosis. This study assesses improvements in clients' employment in a phase of illness during which functional abilities often decline.
METHODS: The trial design is an assessor-blinded randomized clinical trial, set in the context of a population-based Early Psychosis Intervention program in British Columbia, Canada. Participants were randomized either to 1 year of employment support added to treatment-as-usual, or the latter alone. Interviews at intake captured data regarding demographics, symptom severity, and employment; assessments at 6 and 12 months repeated queries about employment activities.
RESULTS: A total of 109 clients were recruited. Employment rates in the Individual Placement and Support group increased over time, unlike the control group. Further, the number of days worked over the 12-month intervention period, compared to the 6 months prior to the study, improved for both groups, but the increase was greater among clients receiving IPS. Sensitivity analysis indicated the advantage in days worked was evident in the second half of the intervention period (6-12 months), but not the first half.
CONCLUSIONS: Employment rates, for younger clients in both early-psychosis groups, were high compared to older clients in later stages of illness. In this study, use of the Individual Placement and Support strategy further increased employment, despite the high baseline rates. Further research is needed to identify the optimal timing of employment support for these clients.
© 2020 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  early psychosis; supported employment; vocational rehabilitation; young adults

Year:  2020        PMID: 32578960     DOI: 10.1111/eip.13005

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  5 in total

1.  A Systematic Review and Meta-analysis of IPS Supported Employment for Young Adults with Mental Health Conditions.

Authors:  Gary R Bond; Monirah Al-Abdulmunem; Jessica Marbacher; Thomas N Christensen; Vigdis Sveinsdottir; Robert E Drake
Journal:  Adm Policy Ment Health       Date:  2022-10-11

2.  Who benefits from individual placement and support? A meta-analysis.

Authors:  Lars de Winter; Chrisje Couwenbergh; Jaap van Weeghel; Sarita Sanches; Harry Michon; Gary R Bond
Journal:  Epidemiol Psychiatr Sci       Date:  2022-07-11       Impact factor: 7.818

Review 3.  Interventions to improve social circumstances of people with mental health conditions: a rapid evidence synthesis.

Authors:  Phoebe Barnett; Thomas Steare; Zainab Dedat; Stephen Pilling; Paul McCrone; Martin Knapp; Eleanor Cooke; Daphne Lamirel; Sarah Dawson; Peter Goldblatt; Stephani Hatch; Claire Henderson; Rachel Jenkins; T K; Karen Machin; Alan Simpson; Prisha Shah; Martin Stevens; Martin Webber; Sonia Johnson; Brynmor Lloyd-Evans
Journal:  BMC Psychiatry       Date:  2022-04-28       Impact factor: 4.144

Review 4.  Vocational Interventions to Improve Employment Participation of People with Psychosocial Disability, Autism and/or Intellectual Disability: A Systematic Review.

Authors:  Isabelle Weld-Blundell; Marissa Shields; Alexandra Devine; Helen Dickinson; Anne Kavanagh; Claudia Marck
Journal:  Int J Environ Res Public Health       Date:  2021-11-17       Impact factor: 3.390

5.  Protocol: A mixed methods evaluation of an IPS program to increase employment and well-being for people with long-term experience of complex barriers in Vancouver's downtown and DTES.

Authors:  Amanda Kwan; Jonny Morris; Skye P Barbic
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.